Gene Query: GRIN2C

Dataset Description Geneva Score
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 28.11
Transcriptional profiling of microglia; current state of the art and future perspectives 26.7
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 21.59
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 16.4
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 14.13
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 14.13
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.95
MYCL and EP400 are required for Max and MCPyV mediated gene activation 10.78
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 10.14
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 7.93
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 7.61
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.23
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.82
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.39
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 6.38
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 6.38
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 6.32
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 6.32
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 5.38
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.06
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.36
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 4.19
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.94
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.94
Effect of CHKA knockdown on C4-2 cell transcriptome 3.93
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 3.67
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 3.55
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.25
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 3.0
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.99
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.99
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.98
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.98
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.8
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.8
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.71
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.64
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.64
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.52
Identification of HOXB13 target genes responsive to BET inhibitors 2.45
The Glioma-Infiltrating T Cell Receptor Repertoire 2.43
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.42
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.42
RNA-seq melanoma 2.36
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.34
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.34
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.28
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.23
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.23
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.21
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.21
circRNA-sequencing 2.13
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.01
Multiple sclerosis and EAE 1.99
Human optic chiasm from healthy controls and multiple sclerosis patients 1.99
Differetially expressed genes after hTR overexpression in U2OS cells 1.9
Effect of PBK knockdown on C4-2 cell transcriptome 1.84
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.81
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.74
Neonatal and adult human testis defined at the single-cell level 1.7
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 1.65
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 1.65
RNA-seq analysis to identify the genes regulated by p53-SET interplay 1.63
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 1.56
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 1.56
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.54
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.52
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.51
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.43
HEK293 Heat-shock experiment 1.43
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 1.41
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.4
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.4
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.38
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 1.33
The Human Testis Cell Atlas via Single-cell RNA-seq 1.31
RNA-seq in endometrial stromal tumors 1.3
EP400 is required for Max and MCPyV mediated gene activation 1.27
AR-independent prostate cancer is sustained through FGF signaling 1.22
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.12
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.12
Repurposing of promoters and enhancers during mammalian evolution 1.07
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.06
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.0
Co-regulation of splicing by Rbfox1 and hnRNP M 0.99
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.99
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 0.93
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.91
A prostate cancer chromatin interaction map 0.9
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.86
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.85
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 0.81
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.8
Global epigenomic reconfiguration during mammalian brain development 0.78
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.78
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.78
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 0.77
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 0.77
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 0.77
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.74
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.72
Searching for target genes of miR-508/509/506/514 in HCT116 cells 0.71
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.7
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.67
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.63
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.61
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 0.59
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 0.59
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.59
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.57
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.57
Identification of Atrial Fibrillation associated genes and functional non-coding variants 0.57
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.57
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.57
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.56
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.56
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.56
Genome wide expression change in LCC2 and MCF-7 cells 0.56
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.55
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.55
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.55
RNAseq in Alzheimer's Disease patients 0.53
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.53
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.52
Reassessment of Exosome Composition 0.5
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.49
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 0.49
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 0.48
snRNAs as regulators of alternative splicing 0.48
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 0.46
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.46
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.46
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 0.45
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.45
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.45
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.44
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 0.43
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 0.43
ARID1A and ARID1B loss in HCT116 cells 0.43
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 0.42
Interphase condensins regulate ligand-depedent enhancer activation 0.4
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.4
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.4
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.4
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.39
Patient-derived xenograft platform for metastatic melanoma 0.39
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.39
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.38
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.38
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.37
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.36
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 0.36
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.36
4sU-seq of HFF exposed to salt and heat stress 0.36
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.36
RNA-Seq of the corpus callosum from 12 individuals 0.35
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.34
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 0.34
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 0.34
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.33
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.33
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 0.33
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.33
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.33
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 0.33
Neurofibroma 0.33
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 0.32
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 0.32
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.32
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.32
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.32
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 0.32
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 0.31
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 0.31
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 0.31
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.3
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.3
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.3
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.29
DRB/GRO-Seq -/+ UV 0.29
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 0.29
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 0.29
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.29
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.28
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.28
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 0.28
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.28
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 0.28
Leucegene: AML sequencing (part 6) 0.28
Genome-wide functional assessment of enhancer activities in the human genome 0.28
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.28
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 0.27
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 0.27
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 0.27
Enhancer activation during EGF response 0.26
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.26
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.26
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.25
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 0.25
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.25
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 0.25
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 0.25
CUREfast: Accelerating research with families 0.25
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.24
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.24
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.24
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.24
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.24
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 0.24
RNA seq with AML (NB4) cells upon FTO inhibition 0.24
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.24
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 0.23
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 0.23
Identification of global regulators of T-helper cell lineage specification 0.23
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 0.23
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 0.22
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.22
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.22
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.22
RNA-sequencing in irradiated and normal A549 cells. 0.22
A role for ZNF598 in post-transcriptional gene regulation 0.22
T47D RNA-seq and ChrRNA-seq data 0.22
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.22
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.21
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.21
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.21
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.21
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 0.21
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 0.21
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 0.21
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 0.21
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 0.21
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 0.2
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.2
CD86 regulates a pro-survival signal in myeloma cells 0.2
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.2
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 0.2
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.2
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.2
The age and genomic integrity of neurons after cortical stroke in humans 0.19
Single-cell analysis of adult human ovary using 10X genomics 0.19
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.19
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 0.19
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 0.19
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.19
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 0.19
HNRNPL and its RNA Targets in Prostate Cancer 0.19
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 0.18
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.18
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 0.18
Disruption of the exocyst induces podocyte loss and dysfunction 0.18
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 0.18
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 0.18
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 0.18
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.18
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.18
Discovering human diabetes-risk gene function with genetics and physiological assays 0.17
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.17
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 0.17
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.17
CD95/Fas ligand mRNA is toxic to cells 0.17
Overexpression and knockdown experiment for circCSNK1G3 0.16
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.16
UV_24h_GRO-Seq 0.16
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 0.16
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 0.16
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.16
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.16
Functional role of CPPED1 in trophoblasts. 0.16
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.16
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.16
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 0.16
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 0.15
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.15
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.15
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.15
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.15
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.15
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 0.15
Gene expression changes after LOC550643 silencing 0.15
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 0.15
SETBP1-WT and SETBP1-G870S epigenetic landscapes 0.15
Gene expression in GBM with Cav3.2 inhibition 0.15
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.15
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.15
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.15
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.15
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 0.15
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.15
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.15
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.15
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 0.15
Myc activation coordinates gene transcription and protein translation responses 0.15
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.15
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.14
High level DNA repair gene expression in human ES cells 0.14
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.14
RNA-seq of human aneuploid cell lines with Trisomy 21 0.14
ARID1A and ARID1B loss in HCT116 and TOV21G cells 0.14
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.14
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.14
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 0.14
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.14
PTHrP overexpression in MCF7 cells 0.14
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.14
Universal alternative splicing of noncoding exons 0.13
Identification of long noncoding RNAs regulated by p53 0.13
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.13
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.13
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.13
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.13
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.13
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 0.13
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 0.13
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.13
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.13
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 0.13
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 0.13
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.12
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.12
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.12
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.12
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.12
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 0.12
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.12
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.12
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.12
Differential gene expression profiles in imatinib-resistant cell lines 0.12
Gene expression profiling in metabolically heterogeneous human lung tumors 0.12
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.11
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.11
Gene expression analysis upon mtDNA depletion 0.11
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.11
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.11
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.11
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.11
Transcriptome analysis of SKI knock-out in HL60 cells 0.11
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.11
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.11
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 0.11
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.11
RNA m5C Methylation in breast cancer using MeRIP-Seq 0.11
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.11
TAF1 is critical for AE driven leukemogenesis 0.11
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 0.11
Leucegene: ALL sequencing 0.11
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 0.1
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.1
CircRNAome diversity in human mature B-cells, T-cells and monocytes 0.1
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.1
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.1
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.1
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.1
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.1
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.1
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.1
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 0.1
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.1
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.1
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.1
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.1
Targeted enhancer activation by a subunit of the integrator complex 0.1
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.09
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.09
Transcriptome of EBV-infected gastric cancer cell lines 0.09
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.09
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.09
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.09
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.09
Analyses of T-ALL (COG study) 0.09
RNA sequencing of T-ALL (COG study) 0.09
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.09
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.09
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.09
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.08
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.08
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.08
RNA-Seq with and without RNase treatment in PCa cell lines 0.08
The MEF2B Regulatory Network - RNA-seq data 0.08
The MEF2B Regulatory Network 0.08
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.08
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.08
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.08
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.08
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.08
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.08
Dysregulated immune system networks in war veterans with PTSD 0.08
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.08
Gene expression activation in CLL mediated by MSCs contact 0.08
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.07
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.07
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.07
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.07
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.07
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.07
6mer seed toxicity in tumour suppressive microRNAs 0.07
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.07
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 0.07
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.07
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.07
MYC dependent mRNA translation shapes gene expression and cell biology 0.07
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.07
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.07
LncRNA-GAS5 negative regulation of YAP-target genes expression 0.07
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.07
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.07
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.06
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.06
mRNA expression profile of Lymphocytes 0.06
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 0.06
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.06
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 0.06
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 0.06
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.06
The DNA methylation landscape of human melanoma 0.06
The DNA methylation landscape of human melanoma [RNA-Seq] 0.06
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.06
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.05
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.05
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.05
Patient-derived luminal breast cancer xenografts with progestins 0.05
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 0.05
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.05
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.05
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.05
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.05
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.05
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.05
hnRNP C is a key regulator of protein synthesis in mitosis 0.05
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.04
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.04
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.04
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.04
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.04
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.04
Overexpression of NFIB and YBX1 in MCF-7 cells 0.04
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.04
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.04
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.04
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.04
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.04
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.04
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.04
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.04
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.03
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.03
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.03
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.03
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.03
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.03
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.03
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.03
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.03
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.03
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.02
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.02
Human ovarian granulosa cell transcriptome 0.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.02
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.02
Characterization of the Merkel cell carcinoma miRNome 0.02
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.02
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.02
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.02
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.02
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.02
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.01
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.01
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.01
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.01
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.01
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.01
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.01
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.01
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.01
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.01
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.01
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.0
RNA-seq of SCLC PDX models treated with EP 0.0
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.0
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.0
Reprogrammed myeloid cell transcriptomes in NSCLC 0.0
JAK dependent survival of ALK- ALCL 0.0
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.0
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.0
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.0
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.0
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.0
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.0
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.0
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.0
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.0
Iron response of HepG2 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation